Peer-reviewedCC BYFrontiers in pharmacology
Targeting the NLRP3 inflammasome in rheumatoid arthritis fibroblast-like synoviocytes: pathogenic mechanisms, therapeutic strategies, and translational perspectives
- 1Department of Laboratory Medicine, People’s Hospital of Anshun City , ,
- 2School of Clinical Laboratory Science, Guizhou Medical University , ,
Related
- Sanguinarine ameliorates rheumatoid arthritis by activating the Hippo-YAP/TAZ pathway to induce apoptosis and suppress inflammation in fibroblast-like synoviocytes
- JQ1 Inhibits the Hyperproliferation and Aggressiveness of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via Regulating IL7R.
- Autophagy in Pituitary Neuroendocrine Tumors (PitNETs): Molecular Mechanisms, Secretory Homeostasis, Therapeutic Resistance, and Translational Perspectives
- Microenvironment-Triggered Sequentially Targeted Micelles for Dual Regulation of Macrophages and Fibroblast-Like Synoviocytes via ROS-Responsive Rg1 Release and HAP-1-Mediated Celastrol Delivery in Rheumatoid Arthritis Therapy.
- Hydrogel-based delivery of extracellular vesicles for skin wound healing: design strategies, therapeutic mechanisms, and translational perspectives
BibTeX
@article{bao2026targeting,
title = {{Targeting the NLRP3 inflammasome in rheumatoid arthritis fibroblast-like synoviocytes: pathogenic mechanisms, therapeutic strategies, and translational perspectives}},
author = {Lunmin Bao and Haibing Dai and Daoming Wang and Hongmei Jiang},
journal = {Frontiers in pharmacology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13659218},
note = {CC BY},
}
RIS
TY - JOUR
TI - Targeting the NLRP3 inflammasome in rheumatoid arthritis fibroblast-like synoviocytes: pathogenic mechanisms, therapeutic strategies, and translational perspectives
AU - Lunmin Bao
AU - Haibing Dai
AU - Daoming Wang
AU - Hongmei Jiang
PY - 2026
DA - 2026/10/16
JO - Frontiers in pharmacology
UR - https://europepmc.org/article/PMC/PMC13659218
SN - 1663-9812
ER -